Abstract:
PURPOSE: Provided are novel 4,5-dihydroisoxazolylalkylpiperazine derivatives having selective biological activity to dopamine D3 and D4 receptors, and their preparation method by reductive amination in the presence of reductant. CONSTITUTION: 4,5-dihydroisoxazolylalkylpiperazine derivative is represented by the formula(1), wherein R1, R2, R3, R4 and R5 are identical or different from each other, and represents individually hydrogen atom, halogen atom, C1-C6 alkyl group, C1-C6 alkoxy group, C2-C6 alkenyl group, hydroxy group , hydroxymethyl group, aryl group, heteroaryl group, amino group, C1-C6 alkyl amino group, carbonyl group, C3-C8 cycloalkyl group, or C3-C8 heterocyclic group; R6 represents hydrogen atom, halogen atom, alkyl group, C1-C6 alkoxy group, aryl group, pyridyl group, heterocyclic group or pyrimidyl group; X represents CH or nitrogen atom; and n is 3 or 4.
Abstract:
The preparation method for 16-phenoxy prostatrienoic acid (I) and its derivatives consists of (1) opening the ring of 1a-hydroxy-4a- (tetrahydropyran- 2-yloxy)-3B-(3a-tetrahydropyran-2-yloxy)-4-phenoxy-19e)buten-1-yl)-cyclopent-2a-yl acetaldehyde lactol (V) with lithium trimethylsilyl acetylide to form 1a-hydroxy-4a- (tetrahydropyran-2-yloxy)-3B-(3a-tetrahydropyran-2-yloxy)-4-phenoxy-19e) but-3-in-2-ol (Ia), (2) rearranging (Ia) with lithium acetylide or ethinyl magnesium halide in tetrahydrofurane to form allen compounds through propargyl ester or ether compounds, to finally obtain (I). (I) is useful for pregnancy control drug when a-hydroxyl group is substituted at carbon position 9, and for control of gastric juice or brochyial expansion when oxygen is at 9.
Abstract:
The present invention relates to 4,5-dihydroisoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 and D4 receptors represented by the following Formula (1), and its preparation method through reductive amination reaction in the presence of reducing agent,wherein R1, R2, X and n are the same as defined in the specification.
Abstract:
본 발명은 16-페녹시 프로스타트리에노산 유도체의 제조에 유용한 중간체(Ⅰ)을 제조하고, 이 화합물을 이용한 다음 일반식(Ⅱ)의 16-페녹시 프로스타트리에노 산 유도체를 제조하는 방법에 관한 것이
상기식에서 R은 테트라하이드로피라닐, 테트라하이드로푸라닐, 2-에톡시에틸 또는 3-t-부틸 디메틸실릴, 트리이소프로필실릴, 트리에틸실릴과 같은 에테르형성그룹으로, R 1 ,R 2 는 수소, 또는 아세틸과 같은 에스테르 형성그룹이고, P는 수소, 트리메틸실릴, 또는 트리부틸틴이고, Z는 산소 또는 α-히드록실기이며, 파상선은 에피입체 혼합물이다.
Abstract:
PURPOSE: Provided is a method for manufacturing an iso-oxazole piperazin compound and its salts which can end up developing a lead compound for new drugs. CONSTITUTION: An isooxazol compound is manufactured by the next step: reacting the compound of the formula (2) with the compound of the formula (3) at room temperature, at 0-7 deg.C, in the presence of organic solvent, 0.1-2 equivalent, preferably 1 equivalent of base, and chlorinating agent for 30 minutes-4 hours, preferably 2 hours. Wherein, organic solvent is selected from benzene, methylene chloride, and tetrahydrofuran; a base is selected from methyl amine, ethyl amine, diethyl amine, dimethyl amine, trimethyl amine, cyclohexylamine, diethylisopropylamine, pyridine, or preferably triethylamine; And chlorinating agent is one of chlorine, N-chlorosuccinimide, and sodium hypochlorite. In the formula (1), (2), and (3), R1 and R6 are a phenyl group, benzyl group, halide phenyl group, phenyl group having substituted C1-C6 alkyl group, phenyl group having substituted C1-C6 alkoxy group, methyl phenyl group, or pyridyl group. R2-R5 is hydrogen, and X is nitrogen.